Last edition
News about
Moderna, Aldevron extends partnership for mRNA vaccine and therapeutic pipeline
Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, and Aldevron, LLC, the leading provider of high-quality plasmid DNA, mRNA and recombinant proteins necessary for vaccines, gene and cell therapy, gene editing and diagnostic applications, have announced their expanded collaboration in support of the Moderna
Zydus Cadila launches Ujvira for breast cancer treatment
Zydus Cadila, a global innovation driven healthcare company, launched trastuzumab emtansine, the first antibody drug conjugate (ADC) biosimilar and a highly effective drug for treating both early and advanced HER2 positive breast cancer, under the brand name 'Ujvira'. HER2 positive breast cancer is considered an aggressive form and constitutes 20 to 25%
Glenmark Pharma receives US FDA approval for generic Firazyr injection
Glenmark Pharmaceuticals Limited has received final approval by the United States Food & Drug Administration (FDA) for icatibant injection, 30 mg/3 mL (10 mg/mL) single-dose prefilled syringe, the generic version of Firazyr injection, 30 mg/3 mL (10 mg/mL) single-dose prefilled syringe, of Shire Human Genetic Therapies, Inc
Biogen, Ginkgo Bioworks enter agreement to develop novel gene therapy manufacturing platform
Biogen and Ginkgo Bioworks announced a gene therapy collaboration. Together, the companies aim to redefine the industry standard for manufacturing recombinant adeno-associated virus (AAV)-based vectors
Merck announced V114, the company's investigational 15-valent pneumococcal conjugate vaccine, met its primary immunogenicity and safety endpoints in two trials of the V114 phase 3 pediatric clinical program. These data support the potential use of V114 in healthy infants who may have previously started a pneumococcal vaccination series
Transcenta Holding Limited, a global biotherapeutics company announced that the updated phase I clinical study (NCT04272944) data on the safety and efficacy of MSB2311, a pH-dependent PD-L1 antibody, in Chinese patients with advanced solid tumors and hematological malignancies have been presented as an abstract online publication
MSN Labs launches posaconazole to treat black fungus
MSN Laboratories has launched posaconazole in India under the brand name PosaOne as 100 mg delayed release tablets & 300 mg injections respectively. Posaconazole is a triazole antifungal agent indicated for treating mucormycosis patients
RDIF in discussions on production of Sputnik V for other countries, Dr Reddy's
Dr Reddy's Laboratories, which is in a pact with Russian Direct Investment Fund to sell 125 million people doses (250 million vials) of COVID-19 vaccine Sputnik V in India, is holding parleys with RDIF for acquiring rights for more countries, a senior official of the Indian company said. Dr Reddy's, which had received over two lakh vaccines from RDIF
Cipla's RT-PCR test kit 'ViraGen' launched in India
Cipla Limited announced the commercialisation of a polymerase chain reaction (RT-PCR) test kit 'ViraGen' for Covid-19 in India, in partnership with Ubio Biotechnology Systems Pvt. Ltd
Gamma Biosciences, a global life sciences company serving the advanced therapy market, announced that it has agreed to make a controlling investment in Mirus Bio, an innovator and developer of biomimetic, cell-adaptive lipid-polymer nanocomplexes (LPNCs) for nucleic acid delivery based in Madison, Wisconsin
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy